Kite Pharma, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Four

Kite Pharma, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Four

Kite Pharma, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $297.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-28.

Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2017-02-28

• 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $297.00K.
• 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $308.00K.